Cholangiocarcinoma: Current Knowledge and New Developments

키워드

참고문헌 (89)

1. Everhart JE, "Burden of digestive diseases in the United States part III: liver, biliary tract, and pancreas", Gastroenterology, 136, pp.1134~1144 (2009)
2. Tyson GL, "Risk factors for cholangiocarcinoma", Hepatology, 54, pp.173~184 (2011)
3. Khan SA, "Rising trends in cholangiocarcinoma:is the ICD classification system misleading", J Hepatol, 56, pp.848~854 (2012)
4. Tyson GL, "Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification", Dig Dis Sci, 59, pp.3103~3110 (2014)
5. Witjes CD, "Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survival", HPB (Oxford), 14, pp.777~781 (2012)
6. von Hahn T, "Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany", Scand J Gastroenterol, 46, pp.1092~1098 (2011)
7. Bertuccio P, "A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe", Ann Oncol, 24, pp.1667~1674 (2013)
8. Endo I, "Intrahepatic cholangiocarcinoma:rising frequency, improved survival, and determinants of outcome after resection", Ann Surg, 248, pp.84~96 (2008)
9. Burak K, "Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis", Am J Gastroenterol, 99, pp.523~526 (2004)
10. Chalasani N, "Cholangiocarcinoma in patients with primary sclerosing cholangitis:a multicenter case-control study", Hepatology, 31, pp.7~11 (2000)
11. Kobayashi S, "Risk of bile duct carcinogenesis after excision of extrahepatic bile ducts in pancreaticobiliary maljunction", Surgery, 126, pp.939~944 (1999)
12. Shaib YH, "Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study", Gastroenterology, 128, pp.620~626 (2005)
13. Welzel TM, "Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database", Hepatology, 54, pp.463~471 (2011)
14. Weber SM, "Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes", J Am Coll Surg, 193, pp.384~391 (2001)
15. Raggi C, "Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts", J Hepatol, 62, pp.198~207 (2015)
16. Kosters A, "The role of inflammation in cholestasis:clinical and basic aspects", Semin Liver Dis, 30, pp.186~194 (2010)
17. Yoon JH, "Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line", Gastroenterology, 122, pp.985~993 (2002)
18. Chan-On W, "Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers", Nat Genet, 45, pp.1474~1478 (2013)
19. Jiao Y, "Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas", Nat Genet, 45, pp.1470~1473 (2013)
20. Ong CK, "Exome sequencing of liver fluke-associated cholangiocarcinoma", Nat Genet, 44, pp.690~693 (2012)
21. Andersen JB, "Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors", Gastroenterology, 142, pp.1021~1031.e15 (2012)
22. Saha SK, "Mutant IDH inhibits HNF-4alpha to block hepatocyte differentiation and promote biliary cancer", Nature, 513, pp.110~114 (2014)
23. Voss JS, "Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions", Hum Pathol, 44, pp.1216~1222 (2013)
24. Sia D, "Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma", Nat Commun, 6, pp.6087~ (2015)
25. Borad MJ, "Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma", Curr Opin Gastroenterol, 31, pp.264~268 (2015)
26. Sia D, "Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes", Gastroenterology, 144, pp.829~840 (2013)
27. Farges O, "AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: Bby the AFC-IHCC-2009study group", Cancer, 117, pp.2170~2177 (2011)
28. Wang Y, "Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy", J Clin Oncol, 31, pp.1188~1195 (2013)
29. Uenishi T, "Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the study group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery", J Hepatobiliary Pancreat Sci, 21, pp.499~508 (2014)
30. Deoliveira ML, "New staging system and a registry for perihilar cholangiocarcinoma", Hepatology, 53, pp.1363~1371 (2011)
31. Chaiteerakij R, "A new clinically based staging system for perihilar cholangiocarcinoma", Am J Gastroenterol, 109, pp.1881~1890 (2014)
32. Hong SM, "Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma", Surgery, 146, pp.250~257 (2009)
33. Morimoto Y, "Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma", J Hepatobiliary Pancreat Surg, 10, pp.432~440 (2003)
34. Tao LY, "Comparison of serum tumor markers for intrahepatic cholangiocarcinoma and hepatocellular carcinoma", Am Surg, 76, pp.1210~1213 (2010)
35. Galassi M, "Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound", Liver Int, 33, pp.771~779 (2013)
36. Rimola J, "Cholangiocarcinoma in cirrhosis:absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma", Hepatology, 50, pp.791~798 (2009)
37. Annunziata S, "Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in the evaluation of the primary tumor in patients with cholangiocarcinoma:a meta-analysis", Biomed Res Int, 2014, pp.247693~ (2014)
38. Park TG, "Implication of lymph node metastasis detected on 18F-FDG PET", CT for surgical planning in patients with peripheral intrahepatic cholangiocarcinoma, 2014, pp.39, 1~7
39. Kim JY, "Clinical role of 18F-FDG PETCT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging", Am J Gastroenterol, 103, pp.1145~1151 (2008)
40. Patel AH, "The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis", Am J Gastroenterol, 95, pp.204~207 (2000)
41. Levy C, "The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis", Dig Dis Sci, 50, pp.1734~1740 (2005)
42. Sinakos E, "Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma", Clin Gastroenterol Hepatol, 9, pp.434~439.e1 (2011)
43. Manfredi R, "Magnetic resonance imaging of cholangiocarcinoma", Semin Liver Dis, 24, pp.155~164 (2004)
44. Masselli G, "MR imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma: correlation with surgical and pathologic findings", Eur Radiol, 18, pp.2213~2221 (2008)
45. Chen HW, "Preoperative assessment and staging of hilar cholangiocarcinoma with 16-multidetector computed tomography cholangiography and angiography", Hepatogastroenterology, 56, pp.578~583 (2009)
46. fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer, "Hepatology", 2001, 1029~1035
47. Moon CM, "Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas", J Gastroenterol Hepatol, 23, pp.759~765 (2008)
48. Navaneethan U, "Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and metaanalysis", Gastrointest Endosc, 79, pp.943~950.e3 (2014)
49. Trikudanathan G, "Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and metaanalysis", Gastrointest Endosc, 79, pp.783~789 (2014)
50. Manta R, "SpyGlass single-operator peroral cholangioscopy in the evaluation of indeterminate biliary lesions: a single-center, prospective, cohort study", Surg Endosc, 27, pp.1569~1572 (2013)
51. Kalaitzakis E, "Diagnostic and therapeutic utility of single-operator peroral cholangioscopy for indeterminate biliary lesions and bile duct stones", Eur J Gastroenterol Hepatol, 24, pp.656~664 (2012)
52. Gleeson FC, "EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma", Gastrointest Endosc, 67, pp.438~443 (2008)
53. Konstadoulakis MM, "Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome", Surgery, 143, pp.366~374 (2008)
54. Choi SB, "The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival", Ann Surg Oncol, 16, pp.3048~3056 (2009)
55. Lang H, "Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158patients", J Am Coll Surg, 208, pp.218~228 (2009)
56. Nagino M, "Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections", Ann Surg, 258, pp.129~140 (2013)
57. Ebata T, "Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients", Ann Surg, 256, pp.297~305 (2012)
58. Lee SG, "Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience", J Hepatobiliary Pancreat Sci, 17, pp.476~489 (2010)
59. van der Gaag NA, "Preoperative biliary drainage for cancer of the head of the pancreas", N Engl J Med, 362, pp.129~137 (2010)
60. Sewnath ME, "A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice", Ann Surg, 236, pp.17~27 (2002)
61. Aoba T, "Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes", Ann Surg, 257, pp.718~725 (2013)
62. Yoshida T, "Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer", Arch Surg, 137, pp.69~73 (2002)
63. Sakamoto Y, "Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins", Surgery, 137, pp.396~402 (2005)
64. "NCCN clinical practice guidelines in oncology: hepatobiliary cancers" (2016)[URL]
65. Darwish Murad S, "Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma", Hepatology, 56, pp.972~981 (2012)
66. Hong JC, "Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma:a 24-year experience in a single center", Arch Surg, 146, pp.683~689 (2011)
67. Sotiropoulos GC, "Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma: a single-center experience", Transplant Proc, 40, pp.3194~3195 (2008)
68. Bridgewater J, "Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma", J Hepatol, 60, pp.1268~1289 (2014)
69. Valle J, "Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer", N Engl J Med, 362, pp.1273~1281 (2010)
70. Lee J, "Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study", Lancet Oncol, 13, pp.181~188 (2012)
71. Boehm LM, "Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma", J Surg Oncol, 111, pp.213~220 (2015)
72. Ortner ME, "Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study", Gastroenterology, 125, pp.1355~1363 (2003)
73. Paik WH, "Palliative treatment with selfexpandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach", Gastrointest Endosc, 69, pp.55~62 (2009)
74. Chan SM, "Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia", Nat Med, 21, pp.178~184 (2015)
75. Mertens JC, "Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma", Cancer Res, 73, pp.897~907 (2013)
76. DeOliveira ML, "Cholangiocarcinoma:thirty-one-year experience with 564 patients at a single institution", Ann Surg, 245, pp.755~762 (2007)
77. Murakami Y, "Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma", Ann Surg Oncol, 18, pp.651~658 (2011)
78. de Jong MC, "Intrahepatic cholangiocarcinoma:an international multi-institutional analysis of prognostic factors and lymph node assessment", J Clin Oncol, 29, pp.3140~3145 (2011)
79. Ribero D, "Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma:a multi-institutional analysis of 434 patients", Arch Surg, 147, pp.1107~1113 (2012)
80. Hirano S, "Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality", J Hepatobiliary Pancreat Sci, 17, pp.455~462 (2010)
81. Ercolani G, "Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center", J Hepatobiliary Pancreat Sci, 17, pp.329~337 (2010)
82. Unno M, "Major hepatectomy for perihilar cholangiocarcinoma", J Hepatobiliary Pancreat Sci, 17, pp.463~469 (2010)
83. Shimizu H, "Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance:radicality and safety of left-sided hepatectomy", Ann Surg, 251, pp.281~286 (2010)
84. Saxena A, "Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival", Am J Surg, 202, pp.310~320 (2011)
85. Young AL, "Evolution of the surgical management of perihilar cholangiocarcinoma in a Western centre demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion", HPB (Oxford), 13, pp.483~493 (2011)
86. Matsuo K, "The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients", J Am Coll Surg, 215, pp.343~355 (2012)
87. de Jong MC, "The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multiinstitutional analysis of 305 cases", Cancer, 118, pp.4737~4747 (2012)
88. Shimizu Y, "The morbidity, mortality, and prognostic factors for ampullary carcinoma and distal cholangiocarcinoma", Hepatogastroenterology, 55, pp.699~703 (2008)
89. Gores GJ, "Liver transplantation for perihilar cholangiocarcinoma", Dig Dis, 31, pp.126~129 (2013)

관련 논문AI추천